about
Type 1 diabetes risk for human leukocyte antigen (HLA)-DR3 haplotypes depends on genotypic context: association of DPB1 and HLA class I loci among DR3- and DR4-matched Italian patients and controlsDysfunction of lipid sensor GPR120 leads to obesity in both mouse and humanAdult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7.A 10-year (1996-2005) prospective study of the incidence of Type 1 diabetes in Moscow in the age group 0-14 years.Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterization of adult-onset autoimmune diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4.Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromosome 2q31-q33.The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity.Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropic hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies.Assessment of type 1 diabetes risk conferred by HLA-DRB1, INS-VNTR and PTPN22 genes using the Bayesian network approach.C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory studyLatent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-RequirementExcellent Intra and Inter-Observer Reproducibility of Wrist Circumference Measurements in Obese Children and Adolescents.A new expression of diabetes: double diabetes.Obesity, autoimmunity, and double diabetes in youth.Metabolic syndrome and autoimmune diabetes: action LADA 3.Epigenetics in autoimmune diseases with focus on type 1 diabetes.Prevention of type 2 diabetes mellitus: is it feasible?Combination immunotherapies for type 1 diabetes mellitus.The addition of E (Empowerment and Economics) to the ABCD algorithm in diabetes care.Wrist circumference is a clinical marker of insulin resistance in overweight and obese children and adolescents.Circulating Reg1α proteins and autoantibodies to Reg1α proteins as biomarkers of β-cell regeneration and damage in type 1 diabetes.Saxagliptin improves glycaemic control and C-peptide secretion in latent autoimmune diabetes in adults (LADA).Influence of dietary fat and carbohydrates proportions on plasma lipids, glucose control and low-grade inflammation in patients with type 2 diabetes-The TOSCA.IT Study.The "Sapienza University Mortality and Morbidity Event Rate (SUMMER) study in diabetes": Study protocol.Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience.High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7).Imatinib does not substantially modify the glycemic profile in patients with chronic myeloid leukaemia.The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance.Diabetes: Immunotherapy for T1DM--still not there yet.A stochastic mathematical model to study the autoimmune progression towards type 1 diabetes.HLA-dependent autoantibodies against post-translationally modified collagen type II in type 1 diabetes mellitus.Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype.A high-sugar and high-fat diet impairs cardiac systolic and diastolic function in mice.PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity.The Q121 variant of ENPP1 may protect from childhood overweight/obesity in the Italian population.Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes.Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control.Association of beta2 adrenergic receptor polymorphisms and related haplotypes with triglyceride and LDL-cholesterol levels.
P50
Q24646358-B9105DA3-0FD9-4AE4-8835-2D73E1193CEAQ28591078-9F9983B2-3764-440B-ABFE-B466111A28BCQ30538087-40DB91B4-ADD6-4011-8920-071D4E5FC618Q33380417-28F5B8EE-F14E-4481-8264-1869C1FD6313Q33556707-462411EB-820C-4A14-8A6A-A16A959E5358Q34307628-EF08C4FC-D796-4C18-9E43-0DBC3DB7C4A7Q34348367-93D74C9C-A4C9-4CD3-955E-3A9D9B250B81Q34567385-AFA1134F-7705-40C6-BD1B-1C7CD357BCDFQ35048490-0F4AADA9-102A-4AD4-A642-A73D1C698B2CQ35404985-2E8424CB-9D1A-4B03-8AD6-B80A249CD25BQ35740110-1E43A637-697E-46B0-A573-D24CAFF62100Q36050227-B7527DAC-F807-4D5A-8269-B8C4F7D2F267Q36701619-F2123BF3-1DB0-4591-95C3-49A6FA84D153Q36783740-D8F52DFE-8CA5-4164-9FF9-EBDDA2333704Q37022978-0EFC5F3C-8AB3-4022-AE74-9DB67B7B5E02Q38062497-3BF462F9-1C5C-4C00-A54A-C6AC583D7301Q38172492-92389859-555F-46A8-88DF-9A4763E6BFCAQ38358009-AC22502F-31DD-47D6-8FD2-192052336C29Q38386131-5C3A3D06-B1CF-44D6-8C86-0382001D4C8CQ39761699-80CF0351-A7BC-44B8-982F-0FC596DE8D15Q39824563-A1C5DBF6-4E0F-4E47-8C9F-51B1BC18FD23Q40524112-71A87228-BD6B-440A-BD1D-D9FC0D9634C7Q40612062-AEF08511-7B10-4A2F-8C81-2753014D22ECQ41026601-2E4A92F3-6F86-4C13-BD1C-2C01181FFB65Q41634197-F01EFFA2-56F7-462E-8432-9EA99BE36303Q41742171-A79AB254-49EE-4A28-88D2-7E4D55E7B35FQ43283669-3F3CDECE-07DE-4CD0-93C4-79C83C5573ABQ43585460-A9409EB2-EB4B-4255-9AC4-A7B66932B802Q43713917-06EBB19B-E9DC-40DF-956E-7CFD740757C6Q43881917-EAE45BB6-4939-4DDE-BD07-8C8E35C36233Q44002816-B6669A1E-DA8C-4D7D-A31F-094F2B742D66Q44134966-D9780581-7684-4521-A2A9-5BE37936DCFBQ45015977-6223EEE4-A2C1-48F8-9AAD-99251991F4F9Q45143033-A20DC0C8-3BD0-438F-8C73-D6346559D690Q46299618-ECD8B427-AB11-4765-A7D7-703B730CCBADQ46495187-614DAF82-3422-4BE7-B989-69536E44E1BEQ46528457-5E7681E7-3A11-46EE-8A76-BAFA5A13E455Q46708957-A93DB39F-A0F7-4E0A-87E5-E4CDA0F00DF4Q46770114-7C6ECF06-DE4F-4884-A9EB-A0CB60E3F1ABQ46776431-B394B32C-3FDF-4B1E-A8E4-73CE285D2831
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Raffaella Buzzetti
@ast
Raffaella Buzzetti
@en
Raffaella Buzzetti
@es
Raffaella Buzzetti
@nl
Raffaella Buzzetti
@sl
type
label
Raffaella Buzzetti
@ast
Raffaella Buzzetti
@en
Raffaella Buzzetti
@es
Raffaella Buzzetti
@nl
Raffaella Buzzetti
@sl
prefLabel
Raffaella Buzzetti
@ast
Raffaella Buzzetti
@en
Raffaella Buzzetti
@es
Raffaella Buzzetti
@nl
Raffaella Buzzetti
@sl
P1053
K-3090-2016
P106
P21
P31
P3829
P496
0000-0003-1490-6041